Navigation Links
Growth in Biological Technology

Growth spurts

... ever direct observations in real-time of the growth of single nanocrystals in solution, which ... (NCEM), led a team of experts in nanocrystal growth and electron microscopy who combined their skills to observe the dynamic growth of colloidal platinum nanocrystals in solution ...

Microbix Sales Grow 22% For Nine Months

... exchange rates. The forecast is for continued growth in sales. "The 22% sales growth achieved in the nine months ending June 30, 2009 ... revenue in the following six months. We see the growth trend in product volume enjoyed in 2009 ...

ThermoGenesis Provides Update on Fiscal 2009 Results

... said the following factors are expected to drive growth and contribute to improved financial performance ... our quality will enable us to focus on our growth initiatives. We believe through the expansion of ... will be positioned to achieve meaningful growth in revenues during 2010," Engle added. "We ...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... cell responsible for driving tumor initiation, growth and recurrence. Research published in Cell Stem ... cell pathway impacts tumor cell proliferation, growth and recurrence." OMP-21M18 is a monoclonal ... that blocks DLL4 signaling to reduce tumor growth two ways: by reducing cancer stem cell frequency ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... "We were pleased to observe continued sales growth in our Proprietary Medical Products business ... that may provide for more substantial revenue growth potential as compared to our overall product ... Products continued to demonstrate higher revenue growth as compared to our overall product portfolio, ...

The Breast Cancer Therapeutics Market in Australia

... including Epotheliones and Vascular Endothelial growth Factor Receptor (VEGFR) inhibitors." ... through our Pharmaceutical & Biotechnology growth Partnership Services programme. With continuous ... of the Complex Business Universe, the growth Partnership Services programme ensures that you ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... $491 million +20% Product sales growth (excluding ADDERALL XR) at constant exchange ... with the same period in 2008. (2) Sales growth at constant exchange rates ("CER"), which is a ... XR, of $491 million, representing growth of 20% compared to the same quarter last year. ...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

... company focused on the delivery of nervous system growth (neurotrophic) factors for the treatment of ... CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in a multi-center, ... include Alta Partners, MPM Capital, Investor growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE ) ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... supporting the use of GAM to deliver bone growth factors. Cardium believes that future DNA-based ... sustained cellular production of platelet-derived growth factor-B (PDGF-B) protein as a treatment for ... Celsius. PDGF-B protein is a well known bone growth mediator and is already used in several FDA ...

Caliper Life Sciences Reports Second Quarter 2009 Results

... Achieved 8% overall organic revenue growth compared to second quarter 2008 pro forma revenue: Optical Imaging: 17% growth (21% before currency impact) Research: 1% growth (5% before currency impact) CDAS: 14% ...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... to generate year-over-year quarterly revenue growth on a constant currency basis and to deliver ... step in one of our targeted areas of future growth by entering into a collaborative agreement with ... to $1.20, we're now projecting year-over-year growth in full year adjusted diluted EPS of ...

Sanofi-aventis Announces Second Quarter 2009 Results

... in the second quarter of 2009 Strong growth from Lantus(R) (up 26.0%), Lovenox(R) (up 13.3%) ... of Plavix(R) (up 9.6%) growth of 18.4% for the Vaccines business excluding H5N1 contracts(2) Net sales growth of 5.4% in the U.S., 4.6% in Europe and 20.1% in ...

NeoGenomics Reports Second Quarter 2009 Results

... During the second quarter, overall revenue growth was impacted by seasonality in our Florida-based ... second quarter, and particularly with the rate of growth of our business outside of the state of Florida," ... liquidity and flexibility in funding our growth initiatives." Robert Gasparini, the ...

Digitas Health Expands Adding Two Key Locations

... move is a strategic part of the agency's 2010 growth plan. Digitas Health has experienced increased annual revenue growth of approximately 50 percent in each of the last ... Digitas Health has enjoyed a long period of growth and accolades. The company's creative work was ...

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

... block tumor-related vascular endothelial growth factor (VEGF). With its novel mechanism of ... VEGF expression necessary to maintain the growth and function of normal blood vessels. Patients ... production of the protein vascular endothelial growth factor (VEGF) in tumors. PTC discovered PTC299 ...

Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting

... of naturally secreted embryonic proteins, growth factors and contains the first naturally ... product, which contains Wnt proteins and other growth factors important to hair follicle maintenance ... compounds containing bioactive Wnt increase hair growth in humans." While additional clinical ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

... in the development of our long-acting human growth hormone candidate that has the potential to ... developing long-acting versions of human growth hormone, interferon beta and erythropoietin, ... well as GLP-1. The company's long-acting human growth hormone drug candidate, which is expected to ...

Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

... or guidelines on health claims in India is a growth restraining factor. According to a Frost ... & Middle East, "The market has good scope of growth considering the positive growth of the Indian food processing industry in terms ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

... of reported to adjusted (organic) sales growth are on page 7. Operating and pretax ... in the second quarter from global sales growth initiatives and profit enhancement activities ... reaffirmed its full year 2009 organic sales growth expectation in a low single digit range. This ...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... preclinical anti-VEGF (Vascular Endothelial growth Factor) antibody program. Under the terms of the ... antibody program, targets the cancer-promoting growth factor VEGF. Data presented at IBC's 5th Annual ... as Avastin(R) (bevacizumab) in inhibiting tumor growth in a number of models of human cancers, including ...

Neogen Reports 16% Increase in Revenues

... ahead for us, and we will continue to execute the growth strategies necessary to seize the opportunities." ... addition, we were pleased to see our percentage growth in operating income exceed our percentage growth in revenue for the fourth quarter as we continue ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... tough challenges - delivering operational sales growth and reconciled earnings-per-share growth for the second quarter," said Fred Hassan, ... second quarter of 2008, reflecting operational growth of 4 percent and an unfavorable impact from ...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

... & Sullivan: Frost & Sullivan, the growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, growth Consulting and growth Team Membership empower clients to create a ...

OpenQ Posts a 200% Revenue Growth in the First Half of 2009

... OpenQ announces solid revenue growth for the first half of 2009 and is now serving 7 ... announced today a continuing trend of profitable growth amidst global turmoil in the Life Sciences market. OpenQ posted a phenomenal 200% revenue growth in the first half of 2009 as compared to the same ...

Essilor : First Half 2009 Revenue

... - Strong growth in First-Half Revenue, up 9.4% - Operating ... polarized lens in the United States. - Firm growth in entry-level products, where Essilor holds ... in instruments. The strong 6% growth from changes in the scope of consolidation ...

STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained

... included HY1 sales 2nd quarter growth remained high at 9% (organic* 8%), but slowed ... with the very strong start of the year. Sales growth over the first half-year remained strong at 12% ... operations to a subsidiary in Switzerland. growth was more moderate in Southern Europe (up 9%). In ...

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results

... year ago. The increase resulted from significant growth in the sales of new products, most of which were ... the Company's Shining-branded retail outlets, and growth in the bulk additive business. The Company's ... assistants contributed to the rapid revenue growth from new products through its customer-oriented ...

Gerresheimer Holds its own in Difficult Environment

... Plastics) at Prior Year Level - growth in the Pharma Business - Sales Decline in ... This result was mainly attributable to sales growth for pharmaceutical packaging and systems, with ... in focusing the business," Herberg adds. growth for pharmaceutical products Regardless of ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Prostate Cancer Therapeutics Market II-6 growth Drivers II-6 Rise in Prostate Cancer Incidences & Access to Modern Therapeutics Foster growth II-6 Table 2: New Incidences of Prostate ... II-8 Supportive Cancer Drugs Contribute to growth II-8 Select FDA Approved Drugs for Palliative ...

ArborGen and Senesco Announce Wood Quality Results

... technology have shown significantly enhanced growth rates in 3-year-old field trials. Selected ... gravity, between the trees with the enhanced growth attributes and untreated control trees. This is good news as fast tree growth is often associated with lower wood quality. ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

... for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and human erythropoietin ... two new patents covering CTP-enhanced human growth hormone and erythropoietin represent another ... with hGH-CTP, its longer-acting version of human growth hormone, later this year. The issue date for ...

Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

... metabolism, proliferation, and DNA damage. Strong growth in the future will be led by expansion of ... years are forecast to witness both the strong growth for multi-targeted kinase inhibitors, and the ... to regroup to recalibrate and spread through new growth paths. Global sales of Gleevec are ...

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... deceleration in growth. Key factors slowing down growth in the global prescription drugs market include ... and pharmacogenomics, which are spearheading growth in the industry. San ... slowdown in 2009 and 2010, with declines or flat growth expected in mature markets such as the US, Japan, ...

UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases

... impacts of different chemical components. Once growth in serum is accomplished, researchers will often ... so they decided to attempt myelination using the growth medium they have spent years tweaking. ... while serum contains components that promote cell growth it may also contain some that inhibit growth. ...

SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination

... Frost and Sullivan Frost & Sullivan, the growth Consulting Company, partners with clients to accelerate their growth. The company's growth Partnership Services, growth Consulting and Career Best Practices empower ...

Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan

... is a smaller market, it is witnessing rapid growth in terms of both new bio-diesel capacities coming ... bio-diesel, there are several strong drivers of growth for both increased supply as well as demand. ... subsidies or tax exemption, will in turn spur growth for the development of bio-diesel." About ...

PTC Therapeutics Receives $2.6 Million in Government Grants

... of new blood vessels, and supports tumor growth in patients with NF2. PTC299 is a novel, orally ... production of the protein vascular endothelial growth factor (VEGF) in tumors, while sparing ... production of the protein vascular endothelial growth factor, or VEGF, in tumors. PTC discovered ...

Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program

... its existing development pipeline and future growth opportunities to a much larger audience of ... investment community are properly informed of our growth strategy and competitive advantages. We are ... healthcare plan and the long-term, secular growth opportunity in China," said Matthew Hayden, ...

OpenQ is Awarded Prestigious Life Sciences Industry Award

... OpenQ wins the 2009 Global Pharmaceutical CRM growth Strategy Leadership of the Year presented by ... the prestigious 2009 Global Pharmaceutical CRM growth Strategy Leadership of the Year award, presented ... the company that has demonstrated an exceptional growth strategy within the industry. A ...

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

... such as follicle stimulating hormone, human growth hormone, interferon beta, erythropoietin, Factor ... trial with our longer-acting version of human growth hormone, signalling our transformation into a ... developing long-acting versions of human growth hormone, interferon beta and erythropoietin, ...
Other Contents
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/18/2015)... -- As mobile payments become more prevalent amongst ... apps continue to be introduced into the market place at ... industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Google Inc. ... FB ) NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
(Date:5/5/2015)... After record-breaking sales of Extend ... introduces the Cookies & Cream flavor at stores nationwide ... has continually raised the bar for nutritional snacks. ... an unprecedented nutritional profile, backed by international patents and ... will launch additional new products and expand retail availability ...
(Date:5/5/2015)... 2015 Dealing with injuries and medical expenses ... task. Personal injury lawyers are excellent resources for accident victims ... In their latest article , the Jones Firm gives the ... choosing a personal injury lawyer to handle their case. , ... a waste of time if the lawyer does not have ...
(Date:5/5/2015)... The report “Liver Fibrosis ... analysis on the therapeutic development for Liver ... identifying new targets and MOAs to produce ... available at http://www.rnrmarketresearch.com/liver-fibrosis-pipeline-review-h2-2014-market-report.html . , ... Pipeline Review, H2 2014 report include ACROVIS ...
(Date:5/5/2015)... 2015 Texting has become a common and ... some physicians text as a way to communicate with patients ... are doing so to assure medical records are updated after ... risk! When providers transmit protected health information (PHI), or ... the risk of violating the Health Insurance Portability and Accountability ...
(Date:5/5/2015)... 05, 2015 No one cares about health ... Disease Control and Prevention cite multiple sources causing poor ... “Poor indoor air quality (pollution) can bother your eyes, nose, ... lung problems and cancer.” , Toxic chemicals often get into ... food or water, or in some cases, absorb them through ...
Breaking Medicine News(10 mins):Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 3Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3
Other TagsOther Tags